No Glaucoma (N=133336)	Glaucoma (N=2719)	Overall (N=136055)	P-value
sex_at_birth
Male	54433 (40.8%)	1275 (46.9%)	55708 (40.9%)	<0.001
Female	78903 (59.2%)	1444 (53.1%)	80347 (59.1%)
race
White	73100 (54.8%)	1491 (54.8%)	74591 (54.8%)	<0.001
Black	29915 (22.4%)	737 (27.1%)	30652 (22.5%)
Asian	2162 (1.6%)	41 (1.5%)	2203 (1.6%)
Hispanic	23987 (18.0%)	372 (13.7%)	24359 (17.9%)
Other	4172 (3.1%)	78 (2.9%)	4250 (3.1%)
age
Mean (SD)	57.7 (15.6)	71.5 (10.5)	58.0 (15.6)
Median [Min, Max]	59.5 [20.4, 91.5]	73.1 [25.1, 91.2]	59.8 [20.4, 91.5]
DM2
No Diabetes	107956 (81.0%)	1444 (53.1%)	109400 (80.4%)	<0.001
Diabetes	25380 (19.0%)	1275 (46.9%)	26655 (19.6%)
edu_level
Less than a high school degree or equivalent	11507 (8.6%)	243 (8.9%)	11750 (8.6%)	0.098
High School or GED	27150 (20.4%)	509 (18.7%)	27659 (20.3%)
College 1-3 years	39495 (29.6%)	766 (28.2%)	40261 (29.6%)
College graduate or advanced degree	55184 (41.4%)	1201 (44.2%)	56385 (41.4%)
income
<$50k	73809 (55.4%)	1525 (56.1%)	75334 (55.4%)	0.805
$50k-$100k	30864 (23.1%)	653 (24.0%)	31517 (23.2%)
$100k-$150k	14967 (11.2%)	278 (10.2%)	15245 (11.2%)
$150k-$200k	6214 (4.7%)	122 (4.5%)	6336 (4.7%)
>$200k	7482 (5.6%)	141 (5.2%)	7623 (5.6%)
Medication
bupropion	10025 (7.5%)	233 (8.6%)	10258 (7.5%)	0.064
glp_agonist	2517 (1.9%)	40 (1.5%)	2557 (1.9%)
naltrexone	550 (0.4%)	12 (0.4%)	562 (0.4%)
no_med	117505 (88.1%)	2402 (88.3%)	119907 (88.1%)
orlistat	183 (0.1%)	4 (0.1%)	187 (0.1%)
sympathomimetics	2556 (1.9%)	28 (1.0%)	2584 (1.9%)